Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced; D011241:Prednisone / Q000627:therapeutic use*
D009388:Neostigmine; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D008775:Methylprednisolone